JABRX
Price
$49.38
Change
+$0.20 (+0.41%)
Updated
Aug 6 closing price
Net Assets
27.03B
RLBCX
Price
$36.81
Change
+$0.10 (+0.27%)
Updated
Aug 6 closing price
Net Assets
252.49B
Interact to see
Advertisement

JABRX vs RLBCX

Header iconJABRX vs RLBCX Comparison
Open Charts JABRX vs RLBCXBanner chart's image
Janus Henderson Balanced S
Price$49.38
Change+$0.20 (+0.41%)
VolumeN/A
Net Assets27.03B
American Funds American Balanced R3
Price$36.81
Change+$0.10 (+0.27%)
VolumeN/A
Net Assets252.49B
JABRX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JABRX vs. RLBCX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JABRX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 252B vs. JABRX (27B). RLBCX pays higher dividends than JABRX: RLBCX (1.56) vs JABRX (1.46). JABRX was incepted earlier than RLBCX: JABRX (16 years) vs RLBCX (23 years). JABRX (1.07) is less costly to investors than RLBCX (0.89). JABRX is a more actively managed with annual turnover of: 76.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than JABRX: RLBCX (250) vs JABRX (2500). JABRX annual gain was more profitable for investors over the last year : 11.00 vs. RLBCX (10.44). JABRX (36.08) and RLBCX (34.86) have equivalent 5 years return.
JABRXRLBCXJABRX / RLBCX
Total Expense Ratio1.070.89120%
Annual Report Gross Expense Ratio1.070.89120%
Fund Existence16 years23 years-
Gain YTD8.7498.418104%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets27B252B11%
Annual Yield % from dividends1.461.5694%
Returns for 1 year11.0010.44105%
Returns for 3 years28.7230.1795%
Returns for 5 years36.0834.86103%
Returns for 10 years83.7561.84135%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRN148.3220.09
+15.67%
Stride
CFG46.93-0.37
-0.78%
Citizens Financial Group
CMPS4.36-0.12
-2.68%
COMPASS Pathways Plc
CNTB2.13-0.07
-3.18%
Connect Biopharma Holdings Limited
APRE1.64-0.15
-8.38%
Aprea Therapeutics